MindPath Fresno – Fresno, California Spravato Clinics, TMS Therapy Clinics

Last verified: 2026-04-07. Reviewed by Angelica Bottaro.

Known For: Branch of Mindpath Health — a 500+ clinician national psychiatry network founded in 1995 — offering FDA-cleared TMS for both depression and OCD; in-network with most major insurance plans and integrated with full-spectrum psychiatry, therapy, and esketamine services.

HealingMaps Take: BrainsWay Deep TMS opens up OCD treatment on-label — a meaningful advantage over standard NeuroStar-only clinics, since only the H7 coil holds the FDA OCD clearance. Patients pursuing TMS for OCD or anxious depression should confirm the H7 coil specifically (vs the H1 coil used for MDD).

Market Position: One of the TMS providers in the Fresno, CA metro offering Deep TMS — relevant for OCD seekers (only Deep TMS H7 holds the standalone FDA OCD clearance) and patients who want non-focal deeper coil penetration.

TMS protocols at this clinic

The TMS device a clinic operates determines which conditions can be treated on-label. The protocols offered here:

Protocol	Session length	FDA-cleared for
Standard rTMS (10 Hz)	19–37 min	TRD, anxious depression, adolescent MDD (15–21)
Deep TMS (H-coil)	~20 min	TRD, OCD (H7), anxious depression, smoking cessation (H4)
iTBS / theta burst (3-min)	3 min	TRD

For a full breakdown of TMS devices (NeuroStar, BrainsWay, MagVenture, Magstim, Nexstim) and how protocols differ, see our complete guide to TMS therapy.

What to expect at your first appointment

1. Insurance pre-authorization (1–3 weeks). Before treatment begins, the clinic submits a prior-authorization request to your insurer. The request typically requires: a confirmed DSM-5 major depressive disorder diagnosis from a psychiatrist, documented failure of 2 to 4 adequate antidepressant trials (most carriers require at least 6 weeks at therapeutic dose for each), a baseline depression rating scale (PHQ-9, HAM-D, or BDI), and evidence of inadequate response to or contraindication for psychotherapy. About 30–50% of initial requests are denied; the highest-yield appeal is a peer-to-peer review between the clinic’s psychiatrist and the insurer’s medical reviewer (success rate exceeds 60% with full prior-trial documentation).
2. Motor threshold mapping (first session, 30–60 minutes added). The clinician delivers single magnetic pulses to the motor cortex and finds the minimum stimulation intensity that elicits a thumb or finger twitch. This motor threshold value sets dosing for every subsequent session — typically 110 to 120 percent of motor threshold. Re-mapping is non-routine.
3. Daily treatment sessions (5x/week, 19–37 min each for standard rTMS or 3 min for iTBS). You sit in a recliner with hearing protection (the magnetic pulses are loud). The coil is positioned against the scalp; you feel a tapping sensation during stimulation. There is no medication, no IV, no need to fast. Patients commonly read, listen to music, or scroll their phone during the session.
4. Drive home, return to work. No anesthesia means you drive yourself to and from each session. You return to work, school, or your normal day immediately afterward — no chaperone, no recovery period, no integration block. Many patients schedule sessions during a lunch break.

Questions to ask on your consult call

• Which TMS device do you operate? This clinic uses BrainsWay Deep TMS. For OCD, only BrainsWay Deep TMS H7 has standalone FDA clearance. For adolescents (15–21), only NeuroStar (since 2024) and BrainsWay (since 2025) hold the relevant clearances.
• Which protocols are available? Standard 10 Hz rTMS is universal. Ask about iTBS (3-minute sessions, FDA-cleared 2018), Deep TMS (BrainsWay H-coil, FDA-cleared 2013–2025 across multiple indications), and accelerated TMS — particularly SAINT (Magnus-credentialed Stanford protocol, 50 sessions in 5 days, $19,703 CMS hospital reimbursement effective July 2025).
• Do you handle prior authorization in-house? Ask about the clinic’s peer-to-peer review process and what their success rate is when the initial PA is denied.
• Are you in-network with my insurer? Verify network status with BCBS, Aetna, Cigna, UnitedHealthcare, Anthem, Humana, Medicare Part B, or Tricare — and ask about cash-pay package discounts (typically 10–25% off rack rate).
• What does maintenance look like after the acute course? Ask about tapering boosters (weekly × 3 → biweekly × 3 → monthly), PRN booster sessions for early symptom return, and whether they recommend continued antidepressant maintenance during and after TMS.

Frequently asked questions

How much does TMS cost at this clinic?

Cash-pay TMS sessions in Fresno, CA typically run $300 to $500 per session, with the full 36-session course costing $7,200 to $15,000. Premium-metro clinics (NYC, San Francisco, Los Angeles, Boston) charge 30 to 50 percent more. With insurance, copays typically run $0 to $250 per session depending on your deductible status; most patients with employer-sponsored PPO plans pay $500 to $3,000 out-of-pocket for a full course. Many independent clinics offer 10 to 25 percent package discounts for cash-pay patients. TMS is HSA- and FSA-eligible. Contact this clinic directly for their specific cash-pay rates and in-network status with your insurer.

Does insurance cover TMS at this clinic?

Most major commercial insurance plans (BCBS, Aetna, Cigna, UnitedHealthcare, Anthem, Humana), Medicare Part B, and Tricare cover TMS for treatment-resistant major depressive disorder. UnitedHealthcare typically requires 3 failed antidepressant trials; most other carriers require 2. Pre-authorization is mandatory across all major carriers. Coverage for off-label conditions (PTSD, fibromyalgia, bipolar depression, migraine) is rarely approved. Contact this clinic to verify in-network status with your specific insurer and to learn about their prior-authorization handling.

What is the “TMS dip” and will I experience it at this clinic?

The “TMS dip” is a patient-coined term for temporary worsening of mood or symptom intensification that some patients experience roughly mid-course (commonly between sessions 10 and 20) before clinical improvement begins. It’s not a sign that TMS is failing — it usually resolves with continued treatment. If you experience the dip, tell your clinician immediately. They may adjust intensity, frequency, or coil position. Importantly, dropping out before session 20 substantially reduces overall response rate. Patients who push through the mid-course dip generally have better outcomes than those who quit early.

Can I drive myself to and from sessions? Can I work the same day?

Yes. TMS requires no anesthesia, no sedation, and no IV access. Patients drive themselves to sessions, return to work, school, or normal activities immediately afterward, and need no chaperone or recovery period. This is the single largest patient-experience advantage TMS holds over ketamine therapy and ECT. Many patients schedule sessions on lunch breaks. The only post-session sensation is mild scalp tenderness for the first few sessions, which decreases substantially as scalp nerves desensitize.

Which TMS device does this clinic use, and why does it matter?

This clinic operates BrainsWay Deep TMS. The device determines what conditions can be treated on-label. For OCD, only BrainsWay Deep TMS H7 has a standalone FDA clearance. For adolescents 15–21, only NeuroStar (since March 2024) and BrainsWay (since November 2025) hold the relevant indications. Ask the clinic which device they operate before booking.

Does this clinic treat OCD with TMS?

Possibly — but only BrainsWay Deep TMS using the H7 coil holds a standalone FDA clearance for OCD (granted via the De Novo pathway in 2018). MagVenture’s Cool D-B80 has an OCD adjunct clearance. Standard NeuroStar (figure-8 coil) is not FDA-cleared for OCD. This clinic appears to use BrainsWay Deep TMS, which is the FDA-cleared device for OCD. The full OCD course is 29 sessions over 6 weeks with symptom-provocation protocols.

People struggling to overcome the symptoms of treatment-resistant disorders can find relief with transcranial magnetic stimulation (TMS) therapy at MindPath Fresno. The medical center provides TMS therapy to people battling disorders that have not yet responded to traditional medicine. Conditions that can be helped using TMS include depression, OCD, and more. The clinic also utilizes TMS therapy to help people kick nicotine products.

The team at MindPath Fresno consists of highly compassionate and skilled clinicians, technicians, and patient navigators. Together with the patient, all three work as a team toward a common goal of healing. Their main goal is to create unique and tailored plans that provide long-term relief from the debilitating symptoms of various health disorders.

About TMS Therapy

Transcranial magnetic stimulation (TMS) is an FDA-cleared, non-invasive treatment for major depression and OCD. A typical course runs 30–36 sessions over 6–9 weeks, with most insurers covering treatment after a documented failure of two antidepressants. See our TMS therapy clinic directory for more options.

See more options nearby in our California tms therapy clinic directory.

Location